In previous publications, we tried to explain the metabolic rewiring of tumor cells by considering that tumor cells respond to both anabolic insulin and to catabolic glucagon, since enzymes such as PK and PDH remain phosphorylated, as for glucagon-mediated neoglucogenesis. This evidence concerns the gene PDP1 and neoplasm.